Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
4,138.46
3,698.90
2,994.05
10,253.28
8,608.43
8,651.88
7,962.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,138.46
3,698.90
2,994.05
10,253.28
8,608.43
8,651.88
7,962.71
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
920.16
927.50
805.63
3,068.46
2,436.95
2,768.05
2,524.97
(Increase) / Decrease In Stocks
18.17
-11.63
-26.42
-176.69
111.96
-228.79
-105.13
Employee Cost
760.39
675.93
541.92
3,264.46
2,755.36
2,903.93
2,688.18
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
29.21
24.07
22.01
814.77
643.42
688.83
600.37
Selling and Distribution Expenses
921.17
815.62
647.29
254.73
275.90
33.64
0.00
Other Expenses
724.83
689.46
554.54
1,544.30
1,322.05
1,228.61
1,391.27
Total Expenditure (Excl Depreciation)
3,373.93
3,120.95
2,544.97
8,770.03
7,545.64
7,394.27
7,099.66
Operating Profit (PBDIT) excl Other Income
764.53
577.95
449.08
1,483.25
1,062.79
1,257.61
863.05
Other Income
148.23
24.85
36.90
50.66
49.97
37.87
34.62
Operating Profit (PBDIT)
912.76
602.80
485.98
1,533.91
1,112.76
1,295.48
897.67
Interest
123.81
110.30
87.26
257.02
293.66
359.67
179.18
Exceptional Items
5,021.06
6.88
315.90
0.00
0.00
-19.64
-1.52
Gross Profit (PBDT)
738.81
492.50
398.72
1,276.89
819.10
916.17
716.97
Depreciation
248.84
219.97
192.04
640.58
617.57
585.94
306.47
Profit Before Tax
489.97
272.53
206.68
636.31
201.53
330.23
410.50
Tax
134.37
56.51
35.87
35.80
27.22
15.38
42.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
355.60
216.02
170.81
600.51
174.31
314.85
367.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
5,071.20
6.88
315.90
0.00
0.00
0.00
0.00
Net Profit
5,426.80
222.90
486.71
600.51
174.31
314.85
367.56
Share in Profit of Associates
-18.91
-11.34
-11.22
0.54
3.52
-0.19
-0.25
Minority Interest
-30.06
-82.28
-50.58
-75.06
-30.09
-38.05
-34.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,377.83
129.28
424.91
525.99
147.74
276.61
333.11
Equity Capital
499.52
499.52
499.52
497.22
497.04
499.52
505.23
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
2,928.55
4,060.27
3,948.55
3,456.19
2,875.42
2,772.62
2,708.53
Earnings per share (EPS)
107.66
2.59
8.51
10.58
2.97
5.54
6.59
Diluted Earnings per share
107.85
2.6
8.53
10.57
2.97
5.5
6.62
Operating Profit Margin (Excl OI)
18.47%
15.62%
15.0%
14.47%
12.35%
14.54%
10.84%
Gross Profit Margin
17.85%
13.31%
13.32%
12.45%
9.52%
10.59%
9.0%
PAT Margin
8.14%
5.53%
5.33%
5.86%
2.07%
3.64%
4.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 11.88% vs 23.54% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 4,059.83% vs -69.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 32.28% vs 28.70% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 12.25% vs 26.40% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Aster DM Health. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
4,138.46
5,482.98
-1,344.52
-24.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,138.46
5,482.98
-1,344.52
-24.52%
Raw Material Cost
0.00
1,140.91
-1,140.91
-100.00%
Purchase of Finished goods
920.16
0.00
920.16
(Increase) / Decrease In Stocks
18.17
-4.53
22.70
501.10%
Employee Cost
760.39
1,092.72
-332.33
-30.41%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
29.21
932.40
-903.19
-96.87%
Selling and Distribution Expenses
921.17
0.00
921.17
Other Expenses
724.83
1,045.09
-320.26
-30.64%
Total Expenditure (Excl Depreciation)
3,373.93
4,206.59
-832.66
-19.79%
Operating Profit (PBDIT) excl Other Income
764.53
1,276.39
-511.86
-40.10%
Other Income
148.23
92.04
56.19
61.05%
Operating Profit (PBDIT)
912.76
1,368.43
-455.67
-33.30%
Interest
123.81
146.41
-22.60
-15.44%
Exceptional Items
5,021.06
-7.55
5,028.61
66,604.11%
Gross Profit (PBDT)
738.81
1,213.66
-474.85
-39.13%
Depreciation
248.84
278.11
-29.27
-10.52%
Profit Before Tax
489.97
935.54
-445.57
-47.63%
Tax
134.37
145.72
-11.35
-7.79%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
355.60
789.82
-434.22
-54.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
5,071.20
0.81
5,070.39
625,974.07%
Net Profit
5,426.80
790.63
4,636.17
586.39%
Share in Profit of Associates
-18.91
0.00
-18.91
Minority Interest
-30.06
-0.48
-29.58
-6,162.50%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,377.83
790.16
4,587.67
580.60%
Equity Capital
499.52
204.36
295.16
144.43%
Face Value
10.00
10.00
0.00
Reserves
2,928.55
3,421.99
-493.44
-14.42%
Earnings per share (EPS)
107.66
38.67
68.99
178.41%
Diluted Earnings per share
107.85
38.90
68.95
177.25%
Operating Profit Margin (Excl OI)
18.47%
23.28%
0.00
-4.81%
Gross Profit Margin
17.85%
22.14%
0.00
-4.29%
PAT Margin
8.14%
14.40%
0.00
-6.26%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 4,138.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.88% vs 23.54% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 5,377.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4,059.83% vs -69.57% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 764.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.28% vs 28.70% in Mar 2024
Annual - Interest
Interest 123.81 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.25% vs 26.40% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.47%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






